AREGAI GIRMAY: Open Payments
NPI 1295731271 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 33 payments from 8 companies in 2025. Trend: 2023 $391 · 2024 $361 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $207 |
| ViiV Healthcare Company | 8 | $175 |
| ABBVIE INC. | 3 | $78 |
| Novo Nordisk Inc | 4 | $73 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| PFIZER INC. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: APRETUDE, DOVATO, QULIPTA, PIFELTRO, Wegovy, SHINGRIX, Biktarvy, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
